MUII-plus End of Year Message – Prof. Damalie Nakanjako (co-Director MUII-plus)

TO All MUII fellows, alumni, partners and collaborators

It is my great pleasure to congratulate the MUII family upon successful completion of a challenging albeit very productive 2020. The unprecedented COVID19 pandemic has allowed us to demonstrate the passion, resilience and relevance of the MUII family in advancing science to improve health care. I appreciate the flexibility, innovation and adaptability that the team has shown to manage and take on the “New Normal” and minimize the negative effects of the unprecedented disruptions. Each one of you has made significant contributions to the national response to the COVID 19 pandemic in your respective fields of research, diagnostics, case management, prevention and advocacy and many of you have attracted funding to support these activities. Such an enthusiastic and comprehensive response to the COVID 19 pandemic was MUII’s dream in building capacity for infection and immunity science to improve the local responses to common infections and preparedness to handle any emerging infections of local and global health importance.

I congratulation all MUII fellows, alumni, partners and collaborators that have won research funding in 2020 as well as MUII trainees who graduated in 2020, and I convey my best wishes to all of you who are awaiting decisions on applications submitted in 2020 (including MUII3). We extend our special thanks to all our partners and collaborators and Center members; without whom MUII would not be the success it is today.

On behalf of MUII I pledge our unwavering support to everyone to respond to several funding opportunities in 2021. Please remember to take time off to rest, recuperate and re-charge for an exciting and fruitful 2021. On behalf of MUII and on my own behalf, I wish you a Merry Christmas and Prosperous New year

Warm regards,

Professor Damalie Nakanjako

Principal College of Health Sciences, Makerere University

Co-director Makerere University Uganda Virus Research Institute (MUII) Capacity building program